RenovoRx (RNXT) Preferred Stock Liabilities (2020 - 2026)
RenovoRx's (RNXT) quarterly Preferred Stock Liabilities came in at $350000.0 in Q2 2026, down 72.76% year-over-year from $1.3 million in Q2 2025, and down 50.07% quarter-over-quarter from $701000.0 in Q1 2026.
Analysis
RenovoRx (RNXT) Preferred Stock Liabilities (2020 - 2026) Analysis & Trends
RenovoRx has disclosed Preferred Stock Liabilities across 5 years of filings, most recently posting $350000.0 for Q2 2026.
- In Q2 2026, Preferred Stock Liabilities fell 72.76% year-over-year to $350000.0; the TTM figure through Jun 2026 stood at $350000.0 (down 72.76% YoY), while the FY2025 annual figure was $604000.0, down 60.24% from the prior year.
- Preferred Stock Liabilities came in at $350000.0 for Q2 2026 at RenovoRx, down from $701000.0 in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $3.4 million in Q2 2023 to a low of $350000.0 in Q2 2026.
- Average Preferred Stock Liabilities over 4 years is $1.5 million, with a median of $1.3 million recorded in 2025.
- Year-over-year, Preferred Stock Liabilities fell 6.57% in 2025 and slumped 72.76% in 2026.
- Over 4 years, Preferred Stock Liabilities stood at $3.3 million in 2023, then slumped by 53.84% to $1.5 million in 2024, then sank by 60.24% to $604000.0 in 2025, then sank by 42.05% to $350000.0 in 2026.
- Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $350000.0 in Q2 2026, $701000.0 in Q1 2026, and $604000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | RenovoRx | 83.48 Mn | 83.48 Mn | 766,000.00 | 350,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 350,000.00 |
| Mar 31, 2026 | 701,000.00 |
| Dec 31, 2025 | 604,000.00 |
| Sep 30, 2025 | 1.11 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 935,000.00 |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 3.29 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 3.43 Mn |
| Dec 31, 2020 | 12.45 Mn |